Intelligent Oral Suspension System for Baclofen
Legal Citation
Summary of the Inventive Concept
A novel system integrating AI, IoT, blockchain, and advanced materials to ensure the stability and authenticity of oral suspensions of baclofen, enhancing patient safety and treatment outcomes.
Background and Problem Solved
The original patent provided stable oral suspensions of baclofen, but it did not address the need for real-time monitoring, automation, and verification of suspension stability and authenticity. The new inventive concept solves this problem by introducing synergistic combinations of distinct technologies to create a more powerful system.
Detailed Description of the Inventive Concept
The system consists of a sensor for detecting pH levels and temperature fluctuations in the suspension, a microcontroller for processing data and adjusting the suspension composition accordingly, and a communication module for transmitting stability data to a remote monitoring platform. Additionally, the system incorporates machine learning algorithms for optimizing suspension stability, a blockchain-based ledger for tracking and verifying authenticity, and novel material compositions for enhanced bioavailability and stability.
Novelty and Inventive Step
The new claims introduce a synergistic combination of AI, IoT, blockchain, and advanced materials to create a more powerful system, which is not obvious from the original patent. The integration of these distinct technologies provides a novel solution for ensuring the stability and authenticity of oral suspensions of baclofen.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of sensors, machine learning algorithms, or blockchain platforms. Variations may also include integrating the system with existing pharmaceutical manufacturing processes or using different material compositions for the oral suspensions.
Potential Commercial Applications and Market
The intelligent oral suspension system has significant commercial potential in the pharmaceutical industry, particularly in the areas of neurological disorders, pain management, and pediatrics. The system's ability to ensure the stability and authenticity of oral suspensions can improve patient safety, reduce costs, and enhance treatment outcomes.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulation and drug delivery systems, with specialized expertise in liquid pharmaceutical compositions, suspension stabilization, and medical technology integration
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or related fields, possessing knowledge of drug formulation techniques, stability optimization, sensor technologies, and computational methods for pharmaceutical product development
Obviousness Rationale
A PHOSITA would recognize that the proposed technical variations represent predictable extensions of existing pharmaceutical stabilization and monitoring technologies. The integration of IoT, machine learning, and blockchain represents incremental improvements to known pharmaceutical tracking and quality control methods. The core pharmaceutical suspension principles from the source patent provide a clear foundation for implementing advanced monitoring and authentication technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,524 |
|---|---|
| Title | Stable oral suspensions of baclofen |
| Assignee(s) | ANI Pharmaceuticals, Inc. |